Antiproliferative action of IL6R-targeted antibody tocilizumab for non-small cell lung cancer cells

Author：                

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|5|2283-2288

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.5, 2015-01, pp. : 2283-2288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth inhibitory effects of miR‐221 and miR‐222 in non‐small cell lung cancer cells

By  

Cancer Medicine, Vol. 4, Iss. 4, 2015-04 ,pp. : 551-564

John Wiley & Sons Inc

Access to resources Recommend Favorite

How Affordable are Targeted Therapies in Non-Small Cell Lung Cancer?

By Coate Linda  

Current Treatment Options in Oncology, Vol. 12, Iss. 1, 2011-03 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 6, 2015-07 ,pp. : 694-700

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of PF-02341066 and radiation on non-small cell lung cancer cells

By            

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1094-1100

Spandidos Publications

Access to resources Recommend Favorite

Suppression of nucleosome-binding protein 1 by miR-326 impedes cell proliferation and invasion in non-small cell lung cancer cells

By        

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 1117-1124

Spandidos Publications

Access to resources Recommend Favorite